Literature DB >> 9402403

Coinfection with human immunodeficiency virus and human T-cell lymphotropic virus type I: reciprocal activation with clinical and immunologic consequences.

J Casseb1, M A Hong, S Salomao, A J Duarte, D Gallo, R M Hendry.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9402403     DOI： 10.1086/516969

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

Authors:  Eduardo Samo Gudo; Nilesh B Bhatt; Dulce Ramalho Bila; Celina Monteiro Abreu; Amílcar Tanuri; Wilson Savino; Suse Dayse Silva-Barbosa; Ilesh V Jani
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

2.  Molecular Detection and Clinical Implications of HTLV-1 Infections among Antiretroviral Therapy-Naïve HIV-1-Infected Individuals in Abuja, Nigeria.

Authors:  Idris Abdullahi Nasir; Abdurrahman Elfulaty Ahmad; Anthony Uchenna Emeribe; Muhammad Sagir Shehu; Jessy Thomas Medugu; Adamu Babayo
Journal:  Virology (Auckl)       Date:  2015-12-14

3.  Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.

Authors:  Yuyang Tang; Alvin M George; Oksana Petrechko; Franklin J Nouvet; Stephanie D Sweet; Yuetsu Tanaka; Brian S Imbiakha; Guochun Jiang; Wei Gao; Kathryn Anastos; James E K Hildreth
Journal:  mSphere       Date:  2018-04-04       Impact factor: 4.389

4.  In vitro basal T-cell proliferation among asymptomatic Human T cell Leukemia Virus type 1 patients co-infected with hepatitis C and/or Human Immunodeficiency Virus type 1.

Authors:  Tatiane Assone; Tatiana M Kanashiro; Maira P M Baldassin; Arthur Paiva; Michel E Haziot; Jerusa Smid; Augusto Penalva de Oliveira; Luiz Augusto M Fonseca; Philip J Norris; Jorge Casseb
Journal:  Braz J Infect Dis       Date:  2018-02-28       Impact factor: 3.257
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.